| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $76K | — |
| R&D Expense | $127.7M | +19.6% |
| SG&A Expense | $56.1M | +25.1% |
| Operating Income | -$183.7M | -21.2% |
| Interest Expense | $9K | -25.0% |
| Pre-tax Income | -$163.9M | -26.6% |
| Income Tax | -$598K | -110.0% |
| Net Income | -$61.2M | -72.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.1M | +63.4% |
| Current Assets | $395.9M | +5.8% |
| Total Assets | $441.1M | +4.9% |
| Current Liabilities | $36.2M | +44.6% |
| Total Liabilities | $39.4M | +35.0% |
| Stockholders' Equity | -$995.0M | +9.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$126.4M | -40.3% |
| Capital Expenditures | $29.5M | -13.7% |
| Investing Cash Flow | $20.4M | +106.2% |
| Financing Cash Flow | $144.4M | +1612.0% |
| Free Cash Flow | -$155.9M | -25.4% |